Why the study?
Does sTNF-R1 predict mortality in patients with chronic heart failure?
Does sTNF-R1 predict mortality in patients with chronic heart failure?
sTNF-R1 may be a useful biomarker for identifying high-risk chronic heart failure patients and monitoring anti-TNF-alpha treatment.
Answers are grounded in this paper and cite their sources.
sTNF-R1 may refine mortality risk stratification in chronic heart failure; leaves open its role in guiding therapy or trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rauchhaus et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: